Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report

Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report

The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with COVID-19 is supportive. The most severe patients need sustained life support for recovery. We herein describe the course of a critically ill COV...

Full description

Bibliographic Details
Main Authors: Thomas Tao-Min Huang, Ying-Chun Chien, Chih-Hsien Wang, Sui-Yuan Chang, Jann-Tay Wang, Song-Chou Hsieh, Yu-Chang Yeh, Shih-Chi Ku, Chong-Jen Yu, Bor-Luen Chiang, Shan-Chwen Chang, Ashita Tolwani
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Medicine
Subjects:
COVID-19
cytokine release syndrome
extracorporeal membrane oxygenation
continuous renal replacement therapy
tocilizumab
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.649583/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.649583/full

Similar Items